Cargando…
Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!
Cachexia, and particularly the loss of metabolically active lean tissue, leads to increased morbidity and mortality in affected patients. An impairment of strength and functional status is usually associated with cachexia. A variety of anabolic and appetite-stimulating agents have been studied in pa...
Autores principales: | Thum, Thomas, Springer, Jochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177042/ https://www.ncbi.nlm.nih.gov/pubmed/21966638 http://dx.doi.org/10.1007/s13539-011-0040-8 |
Ejemplares similares
-
Biomarkers for cancer cachexia: where do we stand?
por: Palus, Sandra, et al.
Publicado: (2020) -
Nutrition in cachexia: from bench to bedside
por: Konishi, Masaaki, et al.
Publicado: (2016) -
The 10th year of the Journal of Cachexia, Sarcopenia and Muscle
por: Anker, Markus S., et al.
Publicado: (2020) -
Single‐nucleotide polymorphisms in cachexia‐related genes: Can they optimize the treatment of cancer cachexia?
por: Ishida, Junichi, et al.
Publicado: (2017) -
Cachexia research in Japan: facts and numbers on prevalence, incidence and clinical impact
por: Konishi, Masaaki, et al.
Publicado: (2016)